Click to copy
Click to copy

Rigel: 2Q Earnings Snapshot

August 6, 2019

SOUTH SAN FRANCISCO, Calif. (AP) _ Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported a loss of $20.6 million in its second quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 12 cents.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.

The drug developer posted revenue of $10.4 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $9.2 million.

In the final minutes of trading on Tuesday, the company’s shares hit $2.17. A year ago, they were trading at $2.75.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL

All contents © copyright 2019 The Associated Press. All rights reserved.